Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
The architect of Iran’s military survival remains defiant - 2From Modesty to Administration: Self-improvement in Interactive abilities
- 3Flu activity in US could continue to rise for weeks, top CDC epidemiologist says
- 4Finding Europe's Head Traveler Objections: An Excursion Through Famous Attractions
- 5Investigating Inside Plan and Home Style: Change Your Residing Space
- The most effective method to Alter Your Savvy Bed for A definitive Rest Insight
- Vote In favor of Your Favored Sort Of Dress
- A Manual for Extravagant Vehicles Available in 2024
- Top 20 Style Brands for Pioneers
- RFK Jr. releases new dietary guidelines with emphasis on protein, full-fat dairy
- Major Scottish gangland figure Steven Lyons arrested in Bali
- Merz says army could be involved in mine-clearing from Hormuz
- Manual for Tracking down Spending plan Agreeable Travel Objections
- Sustaining Public activity and Connections: Key Methodologies
